Screening human genes for small alterations performing an enzymatic cleavage mismatched analysis (ECMA) protocol

Molecular Biotechnology

Volumn 37, Issue 3, 2007, Pages 212-219

  Vogiatzakis, Nikolaos ^a   Kekou, Kyriaki ^a   Sophocleous, Christalena ^a   Kitsiou, Sophia ^a   Mavrou, Ariadni ^a   Bakoula, Chrisa ^a   Kanavakis, Emmanouel ^a  

^a UNIVERSITY OF ATHENS   (Greece)

Author keywords

Dystrophin; Heteroduplexes; Mutation screening; Point mutations; Surveyor endonuclease

Indexed keywords

BIOASSAY; CHARACTERIZATION; DISEASES; DNA; GENES; MUSCULOSKELETAL SYSTEM; MUTAGENESIS;

DYSTROPHIN; HETERODUPLEXES; MUTATION SCREENING; POINT MUTATIONS; SURVEYOR ENDONUCLEASE;

MOLECULAR BIOLOGY;

AGAROSE; ENDONUCLEASE; HETERODUPLEX;

ALLELE; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; DUCHENNE MUSCULAR DYSTROPHY; FABRY DISEASE; GENE MUTATION; GENETIC SCREENING; HUMAN; POINT MUTATION; POLYMERASE CHAIN REACTION; STEROID 21 MONOOXYGENASE DEFICIENCY;

ADRENAL HYPERPLASIA, CONGENITAL; BASE PAIR MISMATCH; BASE SEQUENCE; CYSTIC FIBROSIS; DNA MUTATIONAL ANALYSIS; ENDONUCLEASES; FABRY DISEASE; FEMALE; GENES; GENETIC SCREENING; HUMANS; MALE; MUSCULAR DYSTROPHY, DUCHENNE; NUCLEIC ACID HETERODUPLEXES; PEDIGREE; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS, DNA;

APIUM GRAVEOLENS VAR. DULCE;

EID: 36949034092     PISSN: 10736085     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12033-007-0065-6     Document Type: Article

References (25)

1. Balogh, K., Patocs, A., Majnik, J., Racz, K., & Hunyady, L. (2004). Genetic screening methods for the detection of mutations responsible for multiple endocrine neoplasia type 1. Molecular Genetics and Metabolism, 83(1-2), 74-81.
2. Hofstra, R. M., Mulder, I. M., Vossen, R., de Koning-Gans, P. A., Kraak, M., Ginjaar, I. B., van der Hout, A. H., Bakker, E., Buys, C. H., van Ommen, G. J., van Essen, A. J., & den Dunnen, J. T. (2004). DGGE-based whole-gene mutation scanning of the dystrophin gene in Duchenne and Becker muscular dystrophy patients. Human Mutation, 23(1), 57-66.
3. Buzin, C. H., Feng, J., Yan, J., Scaringe, W., Liu, Q., den Dunnen, J., Mendell, J. R., & Sommer, S. S. (2005). Mutation rates in the dystrophin gene: A hotspot of mutation at a CpG dinucleotide. Human Mutation, 25(2), 177-188.
4. Hamed, S. A., & Hoffman, E. P. (2006). Automated sequence screening of the entire dystrophin cDNA in Duchenne dystrophy: Point mutation detection. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics, 141(1), 44-50.
5. Davies, J. F., Redmond, E. K., Cox, M. C., Lalloo, F. I., Elles, R., & Evans, D. G. (2000). 2157delG: A frequent mutation in BRCA2 missed by PTT. Journal of Medical Genetics, 37, e42.
6. Shenk, T. E., Rhodes, C., Rigby, P. W., & Berg, P. (1975). Biochemical method for mapping mutational alterations in DNA with S1 nuclease: The location of deletions and temperaturesensitive mutations in simian virus 40. Proceedings of the National Academy of Sciences of the United States of America, 72(3), 989-993.
7. Yang, B., Wen, X., Kodali, N. S., Oleykowski, C. A., Miller, C. G., Kulinski, J., Besack, D., Yeung, J. A., Kowalski, D., & Yeung, A. T. (2000). Purification, cloning, and characterization of the CEL I nuclease. Biochem, 39(13), 3533-3541.
8. Shi, R., Otomo, K., Yamada, H., Tatsumi, T., & Sugawara, I. (2006). Temperature-mediated heteroduplex analysis for the detection of drug-resistant gene mutations in clinical isolates of Mycobacterium tuberculosis by denaturing HPLC, SURVEYOR nuclease. Microbes and Infection, 8(1), 128-135.
9. Till, B. J., Colbert, T., Codomo, C., Enns, L., Johnson, J., Reynolds, S. H., Henikoff, J. G., Greene, E. A., Steine, M. N., Comai, L., & Henikoff, S. (2006). High-throughput TILLING for Arabidopsis. Methods in Molecular Biology, 323, 127-135.
10. Wienholds, E., van Eeden, F. J., Kosters, M., Mudde, J., Plasterk, R. H., & Cuppen, E. (2003). Efficient target-selected mutagenesis in zebrafish. Genome Research, 13(2), 2700-2707.
11. Oleykowski, C. A., Bronson Mullins, C. R., Godwin, A. K., & Yeung, A. T. (1998). Mutation detection using a novel plant endonuclease. Nucleic Acids Research, 26(20), 4597-4602.
12. Yeung, A. T., Hattangadi, D., Blakesley, L., & Nicolas, E. (2005). Enzymatic mutation detection technologies. Biotechniques, 38(5), 749-58.
13. Shandilya, H., D'Alessio, J. M., O'Connor, K., Durocher, J., & Gerard, G. (2004). Mutation detection using Surveyor nuclease. Biotechniques, 36(4), 702-707.
14. Kanavakis, E., Efthymiadou, A., Strofalis, S., Doudounakis, S., Traeger-Synodinos, J., & Tzetis, M. (2003). Cystic fibrosis in Greece: molecular diagnosis, haplotypes, prenatal diagnosis and carrier identification amongst high-risk individuals. Clinical Genetics, 63(5), 400-409.
15. Kekou, K., Florentin, L., & Metaxotou, C. (1998). 3′ Acceptor splice site mutation in intron 50 leads to mild Duchenne muscular dystrophy phenotype. Human Genetics. Supplement, 1, S209-S212.
16. Kekou, K., Mavrou, A., Florentin, L., Youroukos, S., Zafiriou, D. I., Skouteli, H. N., & Metaxotou, C. (1999). Screening for minor changes in the distal part of the human dystrophin gene in Greek DMD/BMD patients. European Journal of Human Genetics, 7(2), 179-187.
17. Madsen, K. M., Hasholt, L., Sorensen, S. A., Fermer, M. L., & Dahl, N. (1995). Two novel mutations (L32P) and (G85N) among five different missense mutations in six Danish families with Fabry's disease. Human Mutation, 5(3), 277-278.
18. Wedell, A., & Luthman, H. (1993). Steroid 21-Hydroxylase deficiency: two additional mutations in salt-wasting disease and rapid screening of disease-causing mutations. Human Molecular Genetics, 2(5), 499-504.
19. den Dunnen, J. T., & Paalman, M. H. (2003). Standardizing mutation nomenclature: Why bother? Human Mutation, 22(3), 181-182.
20. Till, B. J., Burtner, C., Comai, L., & Henikoff, S. (2004). Mismatch cleavage by single-strand specific nucleases. Nucleic Acids Research, 32(8), 2632-2641.
21. Cotton, R. G., Rodrigues, N. R., & Campbell, R. D. (1988). Reactivity of cytosine and thymine in single-base-pair mismatches with hydroxylamine and osmium tetroxide and its application to the study of mutations. Proceedings of the National Academy of Sciences of the United States of America, 85(12), 4397-4401.
22. Bannwarth, S., Procaccio, V., & Paquis-Flucklinger, V. (2005). Surveyor Nuclease: A new strategy for a rapid identification of heteroplasmic mitochondrial DNA mutations in patients with respiratory chain defects 25(6), 575-582.
23. Qiu, P., Shandilya, H., & Gerard, G. F. (2005). A method for clone sequence confirmation using a mismatch-specific DNA endonuclease. Molecular Biotechnology, 29(1), 11-18.
24. Janne, P. A., Borras, A. M., Kuang, Y., Rogers, A. M., Joshi, V. A., Liyanage, H., Lindeman, N., Lee, J. C., Halmos, B., Maher, E. A., Distel, R. J., Meyerson, M., & Johnson, B. E. (2006). A rapid and sensitive enzymatic method for epidermal growth factor receptor mutation screening. Clinical Cancer Research, 12(3 Pt 1), 751-758.
25. Aartsma-Rus, A., van Deutekom, J. C., Fokkema, I. F., Van Ommen, G. J., & den Dunnen, J. T. (2006). Entries in the Leiden Duchenne muscular dystrophy mutation database: an overview of mutation types and paradoxical cases that confirm the readingframe rule. Muscle & Nerve, 34(2), 135-144.